经皮聚甲基丙烯酸甲酯椎体成形术治疗骨质疏松性椎体压缩骨折：技术要点
Percutaneous polymethylmethacrylate vertebroplasty in the treatment of osteoporotic vertebral body compression fractures: technical aspects.
作者信息
Jensen M E, Evans A J, Mathis J M, Kallmes D F, Cloft H J, Dion J E
机构信息
Department of Radiology, University of Virginia Health Sciences Center, Charlottesville 22908, USA.
出版信息
AJNR Am J Neuroradiol. 1997 Nov-Dec;18(10):1897-904.
PURPOSE
To describe a technique for percutaneous vertebroplasty of osteoporotic vertebral body compression fractures and to report early results of its use.
METHODS
The technique was used over a 3-year period in 29 patients with 47 painful vertebral fractures. The technique involves percutaneous puncture of the involved vertebra(e) via a transpedicular approach followed by injection of polymethylmethacrylate (PMMA) into the vertebral body.
RESULTS
The procedure was technically successful in all patients, with an average injection amount of 7.1 mL PMMA per vertebral body. Two patients sustained single, nondisplaced rib fractures during the procedure; otherwise, no clinically significant complications were noted. Twenty-six patients (90%) reported significant pain relief immediately after treatment.
CONCLUSION
Vertebroplasty is a valuable tool in the treatment of painful osteoporotic vertebral fractures, providing acute pain relief and early mobilization in appropriate patients.
目的
描述一种用于骨质疏松性椎体压缩骨折经皮椎体成形术的技术，并报告其应用的早期结果。
方法
在3年时间里，该技术应用于29例患者的47处疼痛性椎体骨折。该技术包括通过椎弓根入路对受累椎体进行经皮穿刺，随后将聚甲基丙烯酸甲酯（PMMA）注入椎体。
结果
该手术在所有患者中技术上均获成功，每个椎体平均注入PMMA量为7.1 mL。2例患者在手术过程中发生单处无移位肋骨骨折；除此之外，未发现具有临床意义的并发症。26例患者（90%）在治疗后立即报告疼痛明显缓解。
结论
椎体成形术是治疗疼痛性骨质疏松性椎体骨折的一种有价值的工具，可为合适的患者提供急性疼痛缓解和早期活动能力。
Zotero 插件